Skip to main content
Premium Trial:

Request an Annual Quote

Small Wins Big

This week, The Scientist ranks readers' picks for the top 40 places to work in industry in 2011. Notably, the top three firms overall are each staffed by no more than 100 employees. This year, Epizyme — the Cambridge, Mass.-based drug-development company, which has fewer than 50 employees — takes top honors. The Scientist notes the firm's "integrity" and "communications" as its greatest strengths. Another small biotech, Conversant Bio — the Huntsville, Ala., company, headquartered on the Hudson-Alpha Institute for Biotechnology's campus — ranked second this year, and is honored for its "job satisfaction" and "management," according to The Scientist. Rounding out the top three is the Fargo, N.D.-based Aldevron — the plasmid, protein, and antibody services provider, with 50 to 100 staffers — which is noted for its strengths in "communication," as well as its "remuneration and benefits," according to The Scientist.

Full disclosure: The Scientist's Hannah Waters, who authored the articles that accompany the survey data, is a minority investor in GenomeWeb, though has no editorial input in our publications.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.